Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-12-05
1998-09-08
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514429, 514646, 514649, 514414, 514415, 514419, 514422, 548469, 548495, 548517, 548566, 548569, 548571, 548577, 548578, 548579, 548506, 548523, 560 39, 560 41, 560 48, 560 51, 562 30, 562 37, 562 44, 562433, 562439, 562440, 562443, 562444, 562455, 564123, 564161, 564182, A61K 31135, A61K 3140, A61K 31405, C07C 69616, C07C23714, C07D20709, C07D20912
Patent
active
058045953
ABSTRACT:
The invention provides certain amino acid conjugates of substituted heterocycloaryl-)ethyl!acetamides useful for selectively agonizing kappa opioid receptors in mammalian tissue.
REFERENCES:
patent: 4806556 (1989-02-01), Portoghese
Chang, A., et al., "k-Opioid Receptor Selective Affinity Labels: Electrophilic Benzeneacetamides as k-selective Opioid Antagonists", Advance ACS Abstracts, vol. 2, No. 22, J. Med. Chem., 79-80, (Nov. 15, 1994).
Barber, A., et al., "Opiod Agonists and Antagonists: An Evaluation of Their Peripheral Actions in Inflammation," Med. Res. Reviews, 12, 525-562 (1992).
Barlow, J. J., et al., "Structure/Activity Studies Related to acetamides: A Novel Series of Potent and Selective .kappa.-Opiod Agonists," J. Med. Chem., 34, 3149-3158 (1991).
Birch, P.J., et al., "Preparation and Evaluation of Some Hydrophilic Phenylacetyl-peperazines as Peripherally Selective .kappa.-Opiod Agonists," Bioorg. Med. Chem. Lett., 2, 1275-1278 (1992).
Brown, D. R., et al., "The Use of Quanternary Narcotic Antagonists in Opiate Research," Neuropharm., 24, 181-191 (1985).
Costello, G.F., et al., !acetamides: The Use of Conformational Analysis in the Development of a Novel Series of Opioid .kappa. Agonists," J. Med. Chem., 34, 181-189 (1991).
Martin, W. R., "Pharmacology of Opioids," Pharmacol. Reviews, 35, 283-232 (1984).
Rogers, H., et al., "GR94839, a .kappa.-Opioid Agonist with Limited Access to the Central Nervous System, has Antinociceptive Activity," Br. J. Pharmacol., 106, 783-789 (1992).
Shaw, J.S., et al., "ICI 204448: A .kappa.-Opioid Agonist with Limited Access to the CNS," Br. J. Pharmacol., 96, 986-992 (1989).
Simon, E.J., et al., "Opioid Receptor Multiplicity: Isolation, Purification, and Chemical Characterization of Binding Sites," In: Opioids I, Herz, A., (ed.), Springer-Verlag, Berlin, pp. 3-26 (1993).
"K Opioid Receptor Selective Affinity Labels: Electrophilic Benzeneacetamides as K-Selective Opioid Antagonists," A. Chang et al., J. Med. Chem.(1994) 37, 4490-4498.
Chang An-Chih
Portoghese Philip S.
McKane Joseph
Oswecki Jane C.
Regents of the University of Minnesota
LandOfFree
Kappa opioid receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kappa opioid receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa opioid receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1282426